Keywords: GlaxoSmithKline, Genmab, Arzerra, Shionogi, Ospemifene, Leukemia, VVA, Japan filings

Arzerra and ospemifene NDAs submitted in Japan

Article | 02 May 2012

Print This

UK pharma giant GlaxoSmithKline (LSE: GSK) and Danish company Genmab A/S (OMX: GEN) have submitted a New Drug Application ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in